Cantos Ventures — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Sixfold Biosciencesixfold.bioin𝕏Feb 2021
Sixfold develops RNA delivery technology for the biotech industry.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesLondon, GB
George Foot(Founder)inAnna Perdrix Rosell(Founder)inTina Flatau(Director, Promoter)George William Foot(Executive Officer, Director, Promoter)
Co-investorsPi CampusY CombinatorLombardstreet VenturesThe Venture Collective
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.